Organization
Shire Plc
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Shire Plc
... Zug, Switzerland - Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare diseases, announced ...
... company will be acquired and broken up to maximise value. Pharma giant Shire clawed back 44p to £37.09. It plunged 5.4pc the previous day after ...
... have been satisfied with the community college students they have hired is Shire PLC. The company makes drugs for rare diseases and has more than ...
... FTSE 100 drugs firm Shire has admitted it will fail to hit a $20bn (£15bn) sales target ...
... share price," said Stifel analysts. Adding to the downbeat mood, shares in Shire dropped more than five per cent after the pharma firm cut its ...
... previous years: in 2015, the weekend before the conference brought news of Shire's $5.2 billion acquisition of NPS Pharma; in 2016, Shire's $32 billion acquisition ...
... SAN FRANCISCO—Shire has a penchant for making headlines at the J.P. Morgan Healthcare Conference, ...
... pipeline-in-a-drug strategy for the IL-13 inhibitor, for one. Story Monday, 7:19 a.m.: Shire has a penchant for making headlines at the J.P. Morgan Healthcare Conference, ...
... Shire Announces Business Update at 36th Annual J.P. Morgan Healthcare Conference- Projects continued ...
... of lung transplant rejection. The study is being conducted in collaboration with Shire plc at the Rabin Medical Center - Beilinson Hospital in Israel, and ...
... Cambridge, Mass. - Shire plc (LSE: SHP, NASDAQ: SHPG), the global biotechnology leader in rare diseases, today ...
... Cambridge, MA - Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that Xiidra (lifitegrast ophthalmic solution ...
... Shire to present at the 36th Annual J.P. Morgan Healthcare Conference Cambridge, MA ...
... Shire plc (LSE: SHP, NASDAQ: SHPG) (the 'Company'), in accordance with 5.6.1R of the ...
... Companies Act 2006. Further to the announcement on August 21, 2017, Shire plc ('Shire' or the 'Company') confirms that Jeff Poulton stepped down from the ...
... Dublin, Ireland - Shire plc (LSE: SHP, NASDAQ: SHPG) (the 'Company') announces that Dominic Blakemore, Non-Executive Director ...
... Shire files for FDA approval of a new plasma manufacturing facility in Covington, ...
... relators in a $350 million False Claims Act settlement with biotech company Shire asked a Florida federal court on Thursday to reconsider its apportionment plan ...
... marks an important milestone in the personalization of hemophilia care, building on Shire's strong commitment to continued innovation in hematology,' said Howard B. Mayer, M.D., ...
... measured by the change from baseline in Adaptive Behavior Composite (ABC) score. 'Shire is disappointed that the top-line data from this study did not meet ...
... Shire plc (LSE: SHP, NASDAQ: SHPG) (the 'Company') announces that Bill Burns, Senior Independent ...
... more than 40 per cent of its profits in the US. Drugmaker Shire fell back 1.4 per cent following a 3.8 per cent surge in ...
Want to see the full history on Shire Plc? Upgrade to RelSci Pro now!
Start My Free Trial